Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-UMIN000005797
JPRN-UMIN000005797
Completed
未知

Assay for detection of neutralizing antibodies against interferon-beta in multiple sclerosis - Assay for detection of neutralizing antibodies against interferon-beta in multiple sclerosis

Department of Neurology, Tohoku University School of Medicine0 sites100 target enrollmentJune 20, 2011
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsmultiple sclerosis

Overview

Phase
未知
Intervention
Not specified
Conditions
multiple sclerosis
Sponsor
Department of Neurology, Tohoku University School of Medicine
Enrollment
100
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

5% of the patients with interferon-beta-1a and 10% of the patients with interferon-beta-1b revealed to have high titer of neutralizing antibody and seemed to be influenced to clinical course.

Registry
who.int
Start Date
June 20, 2011
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Department of Neurology, Tohoku University School of Medicine

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
eutralizing Antibodies to Interferon beta in patients treated with Rebif New Formulation - NAb development with RNFIFNß-naïve patients fulfilling Poser or McDonald criteria for CDMS or MS and in whom a decision has been made to initiate treatment with RNF (Rebif New Formulation).MedDRA version: 9.1Level: LLTClassification code 10028245Term: Multiple sclerosis
EUCTR2008-008554-23-SEThe Multiple Sclerosis Research Group, Department of Clinical Neuroscience100
Completed
Not Applicable
A Serologic Study to Correlate Beta-IFN NAb Titers to Beta-IFN Induced Biomarker Response in Patients With Multiple SclerosisMultiple Sclerosis
NCT00288990Biogen300
Recruiting
Not Applicable
eutralizing antibody of Interferon beta on multiple sclerosis (Multi-center clinical studies)Multiple sclerosis
JPRN-UMIN000008186Yokohama City University100
Active, not recruiting
Not Applicable
Analysis of the antibody level against interferon beta before and after increase of dose in MS therapy - Interferon beta dose and antibodyMultiple sclerosis
EUCTR2005-001008-37-SESahlgrenska University Hospital100
Completed
Not Applicable
Changes in specific antibody titers and interferon gamma levels after a BNT162b2 vaccine boosterCOVID-19
JPRN-UMIN000048810Fukuoka City Hospital400